IPIX:》...The Company currently is preparing for an End-of-Phase 2 meeting with the FDA to discuss Brilacidin oral rinse continued development in addressing this area of large unmet need. Future clinical applications of Brilacidin in liquid form to treat other indications may potentially include chronic sinusitis and infections related to periodontal disease.”

Impressive that the Brilacidin empire continues to grow to other possible healing medical treatments and where or what's keeping big bio-pharma ramping up on partnership or complete buyout talks along with Prurisol & Kevetrin building a solid foundation for years !!!........Get it Done Leo & IPIX Management !!!